Skip to main
OHI

OHI Stock Forecast & Price Target

OHI Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 22%
Hold 56%
Sell 0%
Strong Sell 0%

Bulls say

Omega Healthcare Investors Inc. has revised its 2025 Funds from Operations (FFO) estimates upward, increasing the projection to $2.81 per share, driven by stronger-than-expected investment volume. The normalized FFO estimate, adjusted for non-recurring items, is now projected at $2.95 per share, up from previous estimates, indicating a more robust financial outlook. Additionally, the stock is experiencing significant positive performance, showing a 12% year-to-date increase compared to a 4% rise in the Vanguard Real Estate ETF, while trading near the higher end of its 10-year valuation range.

Bears say

Omega Healthcare Investors Inc faces ongoing challenges within its operator segment, which raises concerns about its financial stability and growth potential. The company's relative valuation remains a point of contention, complicating the outlook despite a slight increase in adjusted funds from operations (FFO) estimates for 2026, moving from $3.13 per share to $3.22 per share. This adjusted FFO estimate, while above the consensus of $3.10 per share, does not sufficiently mitigate the worries surrounding operational difficulties and market performance.

OHI has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 22% recommend Buy, 56% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omega Healthcare Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omega Healthcare Investors (OHI) Forecast

Analysts have given OHI a Buy based on their latest research and market trends.

According to 9 analysts, OHI has a Buy consensus rating as of Jan 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $46.56, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $46.56, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omega Healthcare Investors (OHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.